Beyond Meat’s international growth and Beyond Immerse pivot offer optionality, but collapsing U.S. volumes, leverage, dilution, and weak economics make BYND a highly speculative downside-skewed reset.
Overview
Beyond Meat is a branded plant-protein company operating across U.S. and international retail and foodservice channels, with products spanning meat analogs and the new Beyond Immerse functional beverage line. The investment case has shifted from scaling a high-growth meat-alternative category to surviving a structural contraction in U.S. demand and funding an unproven adjacent-category pivot. **Q2 2026 revenue fell 8.2% year over year to $68.8 million**, as pounds sold declined 9.5% to 14.5 million; international retail growth of 16.5% was insufficient to offset U.S. retail’s 9.9% decline and U.S. foodservice’s 27.6% decline. Gross margin improved sequentially to 8.5% from 3.4% in Q1, but remained inadequate, while Adjusted EBITDA worsened to a $(27.7) million loss. The $16.4 million GAAP profit was non-recurring, driven by a $57.7 million debt gain and $11.0 million arbitration credit. Debt of $323.8 million versus $186.1 million of cash and restricted cash creates substantial financial risk. After the August 14, 2026 1-for-30 reverse split, the stock traded near $14.00, below the $24.21 200-day moving average and near-term $18.04 50-day resistance. The five-year probability-weighted target is $13.15, below the current reference price, although successful national scaling of Beyond Immerse could produce the $67.06 high-case outcome.